Drug Development
Sobi’s Aspaveli obtains indication extension approval in Europe
The approval for Aspaveli's extended indication is based on data from the APL2-308 (PRINCE) study.
The approval for Aspaveli's extended indication is based on data from the APL2-308 (PRINCE) study.